HOME >> MEDICINE >> NEWS
Despite the best available anti-aids drugs, Jefferson scientists detect active HIV in the bloodstream

They call for better detection and improved drugs to eradicate the virus

The best AIDS drugs are still not quite good enough. Scientists at Jefferson Medical College have found evidence for the first time of actively replicating HIV in the bloodstream of patients taking the most powerful anti-AIDS virus drugs available.

Scientists knew that the combination of drugs known as HAART, highly active antiretroviral therapy, did not eradicate the AIDS virus, despite the fact that the virus could not be detected by conventional means in the patient's blood. But they thought that the drugs had at least arrested the virus from replicating. No one had been able to find active virus in the blood of patients still on the drugs.

Until now.

Roger J. Pomerantz, M.D., professor of medicine, biochemistry and molecular pharmacology, and chief of the division of infectious diseases at Jefferson Medical College of Thomas Jefferson University in Philadelphia, and his co-workers examined 22 HIV-infected patients taking HAART. Using ultrasensitive molecular techniques, he and his team found evidence of active virus in the blood plasma of every patient.

The researchers report their results Nov. 3 in JAMA, the Journal of the American Medical Association.

"No one has shown in patients taking these drugs that the virus spills out of the immune cells it normally infects and into the blood, possibly infecting other cells," says Dr. Pomerantz, who also directs Jefferson's Center for Human Virology. "There had not been replication previously detectable in the bloodstream or in genital fluids.

"It teaches us something if we're going to eradicate the virus," he says. "We need to be able to stop replication before we think about eradication."

Dr. Pomerantz calls for better detection methods as well.

"In the era of HAART, a lot of the new technologies in laboratories need to be more genera
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
1-Nov-1999


Page: 1 2

Related medicine news :

1. Despite legislation, prompt payment for radiology services elusive goal in New Jersey
2. Despite resources, at-risk infants in US fare no better, researchers find
3. Despite Progress, More Action Needed To Protect Medical Students From Exposure To Disease Through Accidental Needlesticks, UCSF Study Finds
4. Many Gay Men Infected With HIV Are Opting To Delay Treatment, Despite Availability Of Drugs
5. Definition of persistent vegetative state available from American Academy of Neurology
6. Countywide forecasts of water use available for Illinois, Midwest
7. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
8. Making emergency contraception readily available does not increase unprotected intercourse
9. Specialist available to discuss the polycystic ovary syndrome (PCOS) and patient quality of life
10. ESA service makes customised maps available to African aid workers
11. Database on blood and marrow stem cell transplants now available online

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2019)... , ... November 15, 2019 , ... ... living with memory impairment, has announced the Best Memory Care Facilities in Amarillo, ... experts, facility features and amenities. , According to the Alzheimer’s Association ...
(Date:11/15/2019)... ... November 15, 2019 , ... PlayCore’s Center ... comprehensive school physical activity programs (CSPAP) on December 3, 2019 at 2 p.m. ... park professionals, this one-hour and 15-minute webinar will discuss the five components of ...
(Date:11/14/2019)... (PRWEB) , ... November 14, 2019 , ... ... cardiologists at Loma Linda University International Heart Institute have performed a ... single access from the axillary artery in the shoulder. The new procedure offers ...
(Date:11/14/2019)... , ... November 14, 2019 , ... ... Drug Administration (FDA) has granted acceptance to file status of its application for ... manifestation in the disease neurofibromatosis type one (NF1). The FDA’s acceptance of the ...
(Date:11/12/2019)... ... November 12, 2019 , ... InteliChart, the ... that Tidewater Physicians Multispecialty Group (TPMG), a network of 220 providers ... patient engagement platform to deliver enhanced patient experience and overall engagement to ...
Breaking Medicine News(10 mins):
(Date:11/14/2019)... ... November 14, 2019 , ... Bioclinica Medical ... that it has reached a milestone in the company’s history: the company has ... submissions from biopharmaceutical clients for therapies and indications subsequently approved by the U.S. ...
(Date:11/14/2019)... NEW YORK (PRWEB) , ... November 14, 2019 ... ... national brand, K-FISH, aimed to promote the quality of Korean seafood and enhance ... two-week-long promotions entitled, "K-Seafood Global Weeks" in many countries. These special events ...
(Date:11/11/2019)... Fla. (PRWEB) , ... November 11, 2019 , ... ... excellence for autologous biologics, is now representing two of the most respected manufacturers in ... Based in Germany, Ameia Med is the leading developer of the ...
Breaking Medicine Technology:
Cached News: